What's new

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Mar 12, 2025 - 17:06
 0
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Next Article

Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/202...

Related Posts

EMEA-002438-PIP02-19-M03

EMEA-002438-PIP02-19-M03

Feb 14, 2025  0

EMA Veterinary Innovation Day, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 March 2025, 13:30 (CET) to 14 March 2025, 12:30 (CET)

EMA Veterinary Innovation Day, Online, European Medicin...

Feb 13, 2025  0

Good manufacturing practice

Good manufacturing practice

Feb 24, 2025  0